Plasma Fractionation Market Rising in United States | Fortune Business Insights

 The global plasma fractionation market size is expected to showcase significant growth by reaching USD 51.83 billion by 2028. This information is published in a report by Fortune Business Insights, titled “Plasma Fractionation Market, 2021-2028.” The report further mentions that the market stood at USD 29.10 billion in 2020 and is likely to exhibit a CAGR of 6.9% between 2021 and 2028. This is attributable to the factors such as the increasing adoption of immunoglobulin and the growing focus on introducing advanced treatment solutions is expected to boost the demand for the product worldwide.

Get Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/sample/plasma-fractionation-market-101614

Takeda Acquires Shire to Strengthen its Footprint in Japan and the U.S.

In January 2019, Takeda Pharmaceutical Company Limited announced the acquisition of Shire plc, a leading biopharmaceutical company having its headquarters in Japan. The acquisition has elevated Takeda’s position in the U.S. and Japan and further strengthened its footprint by developing innovative medicines such as plasma fractionation systems serving around 80 countries globally. Christophe Weber, CEO of Takeda, said, “We are pleased to announce the acquisition earlier than expected. The hard work put by the organization and the smooth regulatory clearances has helped us achieve this feat in a short time. We are highly appreciative of the support received from our employees, shareholders, and partners.”

Increasing Focus on Establishment of Industry Compliant Facilities to Promote Growth

The increasing focus on the development of advanced facilities by major players is perceived as a positive sign in the adoption of the product. For instance, in February 2019, Kedrion Biopharma secured a FDA approval for setting up a plasma manufacturing facility dedicated to plasma proteins in Melville. According to the company, the facility will aid in the process of fractionation of sterile microorganism free environment. Additionally, the high demand for blood plasma during the COVID-19 pandemic is expected to boost the global plasma fractionation market growth in the forthcoming years.

Industry Development:

• March 2020 – Houston Methodist Hospital became the first-ever hospital to try blood transfusion therapy with the help of a patient recovered from the COVID-19. The individual donated his blood plasma for the transfusion termed as convalescent serum therapy.

Market Exhibited a Stellar Growth Rate of 14.4% in 2020; High Demand for Plasma Witnessed Worldwide

In the initial phases of the outbreak of the COVID-19, patients globally were administered with blood plasma therapy to ensure complete recovery in the absence of specific treatment against the pandemic. Besides, the positive response shown by the plasma procedure in the management of disease has bode well for the growth of the market. Owing to this the market exhibited a growth rate of 14.4% in 2020 and is further expected to showcase significant growth in the forthcoming years.

Quick Buy - Plasma Fractionation Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/101614

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com